SCHEMBL23947892

SCHEMBL23947892

c1ccc(-c2nc(-c3ccc4c(c3)oc3cccc(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)c34)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
BACE1 P56817 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
HCRTR1 O43613 1/20 0.32
LMNA P02545 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
PRKDC P78527 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
ALOX5 P09917 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21192248 0.97 KDM4E (0.38) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL21191945 0.97 KDM4E (0.38) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL22330054 0.97 KDM4E (0.39) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL22257643 0.97 KDM4E (0.39) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL21192114 0.96 KDM4E (0.37) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL26169483 0.96 KDM4E (0.37) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL23947894 0.96 KDM4E (0.37) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL21191834 0.96 ATM (0.37) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL23557933 0.96 L3MBTL1 (0.35) KDM4EATML3MBTL1BACE1SMN1; SMN2
SCHEMBL21192103 0.96 KDM4E (0.38) KDM4EATML3MBTL1SMN1; SMN2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 KDM4E 3842/4885ATM 2218/4885L3MBTL1 94/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 KDM4E 3695/4885ATM 2154/4885L3MBTL1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.